Fibromyalgia syndrome (FMS) is a rheumatoid disorder of the muscles and bones that causes pain and fatigue. Patients and doctors understand full well the condition’s devastating effects and how it can prevent people from working – and a new blood test helps make that clear to insurers, too.
Because FMS has traditionally been diagnosed based on subjective evidence reported by patients, insurance companies have routinely denied long-term disability insurance claims to those with FMS. However, an objective test to diagnose fibromyalgia is now available. The FM/a Test is a simple blood test that can usually produce results within a week.
The FM/a Test looks at biomarkers in the patient’s immune system. Fibromyalgia is indicated in tested patients who have irregular protein arrangements, enabling doctors to diagnose and treat the disorder.
Fibromyalgia syndrome symptoms typically include pain in muscles, tendons and joints across the body, but especially along the spine. Other symptoms can include:
- Fatigue
- Headaches
- Feelings of weakness
- Sleep difficulties
- Depression
- Numbness and tingling in hands and feet
- Dizziness
- Memory difficulties
The FM/a Test is good medical news that will enable people with FMS to get treatments that Cedars-Sinai Medical Center says can include anti-depressants and non-steroidal anti-inflammatory drugs.
Patients are also encouraged to reduce stress in their lives and to begin regular aerobic exercise regimens. Doctors say that “with treatment, there can be a significant reduction in symptoms” and that some patients will be able to return to work despite their pain.
The FM/a Test helps patients get the medical help they require and also makes it more difficult for insurers to deny needed long-term disability benefits.
If you or a loved one with FMS has been denied needed and deserved long-term disability insurance benefits, contact the Milwaukee, Wisconsin law office of Alan C. Olson and Associates to discuss your legal options.
